Discover how AI and U.S. manufacturing are revolutionizing drug development and delivery.

At this webinar, attendees can expect to hear about:

• Why drug delivery is often overlooked in early development—and the risks that it creates downstream.
• How AI approaches are reshaping drug development and accelerating timelines.
• Key manufacturing bottlenecks and the advantages of reshoring to the U.S.
• How integrating delivery, AI, and domestic manufacturing early can de-risk programs and speed therapies to clinic.

More information, speakers, registration